Avalo Therapeutics Inc. (AVTX)

New Form 8-K - Avalo Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038570 Size: 446 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits